MedTrace Logo

A Trial of Lu AH69593 in Healthy Participants

NCT07775261 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2026-08-20

No results posted yet for this study

Summary

This trial will evaluate the effects of itraconazole (Part A) and, carbamazepine (Part B) on Lu AH69593, and the effect of Lu AH69593 on midazolam (Part C) in adult healthy participants. The main goals of this trial are to learn about

1. the effect of other medicines on Lu AH69593
2. the pharmacokinetic parameters of Lu AH69593 (how the drug is absorbed, distributed, and processed by the body), and
3. the safety and tolerability of Lu AH69593.

Conditions

  • Healthy Participants

Interventions

DRUG

Lu AH69593

Specified dose on specified days

DRUG

Itraconazole

Specified dose on specified days

DRUG

Carbamazepine

Specified dose on specified days

DRUG

Midazolam

Specified dose on specified days

Sponsors & Collaborators

  • H. Lundbeck A/S

    lead INDUSTRY

Principal Investigators

  • Email contact via H. Lundbeck A/S H. Lundbeck A/S · H. Lundbeck A/S

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-08-27
Primary Completion
2026-11-04
Completion
2026-11-06
FDA Drug
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07775261 on ClinicalTrials.gov